Harvard Catalyst Profiles

Yale University, New Haven, CT	BS	05/2007	Biology
Tufts University School of Medicine, Boston, MA	MD	05/2011
Tufts Medical Center, Boston, MA		06/2014	Internal Medicine Residency
Beth Israel Deaconess Medical Center, Boston, MA		06/2017	Hematology/Oncology Fellowship

I am an academic medical oncologist specializing in genitourinary (GU) cancers. I care for patients with prostate, bladder, kidney, and testicular cancer. I spend approximately half of my time on genitourinary oncology research, particularly focusing on immunotherapy and targeted approaches in prostate, bladder, and kidney cancers, with support from the Prostate Cancer Foundation, NIH, DoD, BIDMC, and industry partners. I am interested in clinical trial development, serving as overall Principal Investigator (PI) and site PI of several Dana-Farber/Harvard Cancer Center (DF/HCC) clinical trials that investigate immune-based, targeted, and radioligand therapies for GU cancers. In addition, I am the Director of GU Oncology Clinical Research for the Beth Israel-Lahey Health network and PI of the DF/HCC GU Rapid Autopsy program, a component of the Pathology core of the DF/HCC Prostate SPORE. In 2024, Newsweek included me in their ranking of "America's Top Prostate Cancer Oncologists." I am passionate about teaching: I am a two-time author of the American Society of Clinical Oncology Self-Evaluation Program GU chapter and a two-time winner of the annual teaching award from our fellowship program. Finally, I have developed tools to improve quality of life, physician communication, and end-of-life decision-making, especially as it relates to patients with GU cancers, and to promote patient wellbeing outside of my clinic, I serve as medical advisor to the Boston Prostate Cancer Support Group and the Massachusetts Prostate Cancer Coalition.